Almotriptan malate is a triptan-class pharmaceutical agent used in the acute treatment of migraine attacks, functioning as a selective agonist at serotonin 5-HT1B and 5-HT1D receptors to constrict intracranial… Read more









![Chemical structure of Almotriptan Related Compound A ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H (1013523)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1018676-02-2-Almotriptan-Related-Compound-A-3-2-Dimethylaminoethyl-5-pyrrolidine-1-ylsulfonylmethyl-1H-1013523.png&w=3840&q=75)
![Chemical structure of Almotriptan Related Compound B (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hem (1013545)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1246860-65-0-Almotriptan-Related-Compound-B-2-5-pyrrolidin-1-ylsulfonylmethyl-1H-indol-3-ylethanamine-hem-1013545.png&w=3840&q=75)
![Chemical structure of Almotriptan Related Compound C (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethan (1013556)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F334981-12-3-Almotriptan-Related-Compound-C-N-methyl-2-5-pyrrolidin-1-ylsulfonylmethyl-1H-indol-3-ylethan-1013556.png&w=3840&q=75)
Almotriptan malate is a triptan-class pharmaceutical agent used in the acute treatment of migraine attacks, functioning as a selective agonist at serotonin 5-HT1B and 5-HT1D receptors to constrict intracranial blood vessels. To support the rigorous analytical demands of pharmaceutical development, this category provides a comprehensive selection of high-quality reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. These compounds, which encompass various salt forms, N-desmethyl derivatives, and dimeric impurities, are essential for impurity profiling, method validation, and routine quality control testing. Laboratories also rely on these materials, including stable isotope labelled compounds and traceable working standards, to ensure accuracy in assay calibration and the quantification of degradation products throughout the lifecycle of the drug product.